{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:29:21Z","timestamp":1791725361256,"version":"4.3.4"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11,30]]},"DOI":"10.1097\/qad.0b013e328311ac4e","type":"journal-article","created":{"date-parts":[[2008,11,13]],"date-time":"2008-11-13T03:10:40Z","timestamp":1226545840000},"page":"2527-2533","source":"Crossref","is-referenced-by-count":44,"title":["Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil"],"prefix":"10.1097","volume":"22","author":[{"given":"Jonathan E","family":"Golub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betina","family":"Durovni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie S","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange C","family":"Cavalacante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio G","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence H","family":"Moulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E","family":"Chaisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Saraceni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210130","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","article-title":"The growing burden of tuberculosis: global trends and interactions with the HIV epidemic","volume":"163","author":"Corbett","year":"2003","journal-title":"Arch Intern Med"},{"key":"R2-13-20210130","first-page":"455","article-title":"The impact of HIV infection on recurrence of tuberculosis in South African gold miners","volume":"4","author":"Mallory","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"R3-13-20210130","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(01)06712-5","article-title":"HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers","volume":"358","author":"Sonnenberg","year":"2001","journal-title":"Lancet"},{"key":"R4-13-20210130","first-page":"105","article-title":"Factors associated with drug resistance in pulmonary tuberculosis","volume":"45","author":"Johnson","year":"2003","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"R5-13-20210130","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/archinte.1997.00440260077012","article-title":"A continuing survey of drug-resistant tuberculosis, New York City, April 1994","volume":"157","author":"Fujiwara","year":"1997","journal-title":"Arch Intern Med"},{"key":"R6-13-20210130","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/archinte.160.5.630","article-title":"Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico","volume":"160","author":"Garcia-Garcia","year":"2000","journal-title":"Arch Intern Med"},{"key":"R7-13-20210130","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1164\/rccm.200409-1200OC","article-title":"Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis","volume":"171","author":"Verver","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R8-13-20210130","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM199910143411602","article-title":"Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment","volume":"341","author":"van Rie","year":"1999","journal-title":"N Engl J Med"},{"key":"R9-13-20210130","first-page":"828","article-title":"Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk","volume":"11","author":"Panjabi","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"R10-13-20210130","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/323784","article-title":"Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City","volume":"33","author":"Driver","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R11-13-20210130","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0140-6736(02)09742-8","article-title":"Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial","volume":"360","author":"Benator","year":"2002","journal-title":"Lancet"},{"key":"R12-13-20210130","first-page":"260","article-title":"Factors affecting relapse following short-course chemotherapy","volume":"53","author":"Aber","year":"1978","journal-title":"Bull Int Union Tuberc"},{"key":"R13-13-20210130","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/archinte.1997.00440230105014","article-title":"Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients","volume":"157","author":"Pulido","year":"1997","journal-title":"Arch Intern Med"},{"key":"R14-13-20210130","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","article-title":"The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil","volume":"21","author":"Golub","year":"2007","journal-title":"AIDS"},{"key":"R15-13-20210130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/1740774507076937","article-title":"Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention","volume":"4","author":"Moulton","year":"2007","journal-title":"Clin Trials"},{"issue":"Suppl 2","key":"R16-13-20210130","first-page":"S62","article-title":"II Brazilian consensus on treatment of tuberculosis \u2013 Brazilian guidelines for tuberculosis 2004 [in Portuguese]","volume":"30","author":"Castelo Filho","year":"2004","journal-title":"J Bras Pneumol"},{"key":"R17-13-20210130","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.annepidem.2005.03.002","article-title":"Why pulmonary tuberculosis recurs: a population-based epidemiological study","volume":"15","author":"Selassie","year":"2005","journal-title":"Ann Epidemiol"},{"key":"R18-13-20210130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2105\/AJPH.78.1.30","article-title":"Recurrent tuberculosis: why do patients develop disease again? A United States Public Health Service cooperative survey","volume":"78","author":"Kopanoff","year":"1988","journal-title":"Am J Public Health"},{"key":"R19-13-20210130","first-page":"1026","article-title":"HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult\/Adolescent Spectrum of HIV Disease Group","volume":"4","author":"Jones","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"R20-13-20210130","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study","volume":"359","author":"Badri","year":"2002","journal-title":"Lancet"},{"key":"R21-13-20210130","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/01.aids.0000194808.20035.c1","article-title":"Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"R22-13-20210130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1183\/09031936.04.00109303","article-title":"Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy","volume":"24","author":"Girardi","year":"2004","journal-title":"Eur Respir J"},{"key":"R23-13-20210130","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"R24-13-20210130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/QAI.0b013e3180decb6a","article-title":"Comparison of clinical response to initial highly active antiretroviral therapy in the patients in clinical care in the United States and Brazil","volume":"45","author":"Grinsztejn","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R25-13-20210130","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1086\/501018","article-title":"Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions","volume":"42","author":"Lawn","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R26-13-20210130","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1097\/QAD.0b013e3282f09876","article-title":"Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa","volume":"21","author":"Moh","year":"2007","journal-title":"AIDS"},{"key":"R27-13-20210130","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0140-6736(00)02870-1","article-title":"Effect of posttreatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a radomised trial","volume":"356","author":"Fitzgerald","year":"2000","journal-title":"Lancet"},{"key":"R28-13-20210130","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1097\/00002030-200309260-00007","article-title":"Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?","volume":"17","author":"Churchyard","year":"2003","journal-title":"AIDS"},{"key":"R29-13-20210130","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1159\/000007239","article-title":"Isoniazid plus sulphadoxine-pyrimethamine can reduce morbidity of HIV-positive patients treated for tuberculosis in Africa: a controlled clinical trial","volume":"45","author":"Haller","year":"1999","journal-title":"Chemotherapy"},{"key":"R30-13-20210130","first-page":"544","article-title":"Community DOT for tuberculosis in a Brazilian favela: comparison with a clinic model","volume":"11","author":"Cavalcante","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"R31-13-20210130","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199709183371201","article-title":"A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration","volume":"337","author":"Whalen","year":"1997","journal-title":"N Engl J Med"},{"key":"R32-13-20210130","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1097\/00002030-200111090-00008","article-title":"Chemoprophylaxis for tuberculosis and survival of HIV-infected patients in Brazil","volume":"15","author":"de Pinho","year":"2001","journal-title":"AIDS"},{"key":"R33-13-20210130","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(97)06532-X","article-title":"Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection","volume":"351","author":"Halsey","year":"1998","journal-title":"Lancet"},{"key":"R34-13-20210130","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0140-6736(93)91817-6","article-title":"Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection","volume":"342","author":"Pape","year":"1993","journal-title":"Lancet"},{"key":"R35-13-20210130","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/00002030-199818000-00014","article-title":"Twice weekly tuberculosis preventive therapy in HIV infection in Zambia","volume":"12","author":"Mwinga","year":"1998","journal-title":"AIDS"},{"key":"R36-13-20210130","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.283.11.1445","article-title":"Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial","volume":"283","author":"Gordin","year":"2000","journal-title":"JAMA"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-200811300-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:31:26Z","timestamp":1786037486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200811300-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,30]]},"references-count":36,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328311ac4e","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11,30]]}}}